|
Changes over time in the quality indicators used for benchmarking in 2007 |
|||||||||
| DKG/DGS requirement |
|||||||||
|
|
|||||||||
| QI No. |
Quality indicator (QI) |
Year of introduction |
2003 |
2004 |
2005 |
2006 |
2007 |
1st year |
3rd year |
|
|
|||||||||
| 1 |
Preoperative histological confirmation of diagnosis |
2003 |
58% |
71% |
78% |
84% |
88% |
90%a |
90%a |
| 2 |
Appropriate axillary dissection |
2003 |
85% |
85% |
80% |
83% |
88% |
85% |
95% |
| [ex-3]b |
Complete tumour staging data |
2003 |
85% |
96% |
98% |
95% |
> 95% |
> 95% |
|
| 3 |
Data on safety distance between tumour and resection margin |
2007 |
91% |
100% |
100% |
||||
| [ex-4]b |
HER-2/neu assessment |
2005 |
94% |
98% |
> 95% |
> 95% |
|||
| 4 |
Specimen radiography |
2007 |
83% |
> 95% |
> 95% |
||||
| 5 |
Hormone receptor assessment |
2003 |
92% |
96% |
96% |
97% |
98% |
100% |
100% |
| 6 |
Appropriate endocrine therapy in hormone receptor-positive patients |
2003 |
27% |
82% |
92% |
94% |
93% |
70% |
95% |
| 7.1 |
Appropriate adjuvant and neoadjuvant chemotherapy |
2003 |
|||||||
| 7.1a |
during the current analysis period; age ≤ 70 years |
2005 |
65% |
75% |
81% |
70% |
80% |
||
| 7.1b |
during the current analysis period; no age limit |
2003 |
32% |
45% |
55% |
63% |
80% |
-- |
-- |
| 7.2 |
Use of appropriate standard regimens in chemotherapy |
2005 |
|||||||
| 7.2a |
during the current analysis period; age ≤ 70 years |
2006 |
65% |
72% |
-- |
-- |
|||
| 7.2b |
during the current analysis period; no age limit |
2005 |
57% |
60% |
69% |
-- |
-- |
||
| 8 |
Percentage of patients in clinical trials |
2005 |
8% |
7% |
7% |
10% |
20% |
||
| 9 |
Appropriate radiotherapy after breast-conserving therapy |
2003 |
20% |
46% |
60% |
70% |
79% |
100%c |
100%c |
| 10 |
Appropriate radiotherapy after mastectomy |
2003 |
8% |
26% |
35% |
47% |
65% |
100%c |
100%c |
| 11 |
Indication for breast-conserving therapy |
2003 |
|||||||
| 11a |
at any tumour stage |
2003 |
64% |
66% |
64% |
68% |
70% |
-- |
-- |
| 11b |
at T1 |
2005 |
79% |
83% |
85% |
50% |
70% |
||
| 11c |
at T2 |
2006 |
60% |
63% |
-- |
-- |
|||
| 11d |
at T3 |
2006 |
15% |
13% |
-- |
-- |
|||
| 11e |
at T4 |
2006 |
15% |
12% |
-- |
-- |
|||
|
a requirement for palpable tumours, 70% for nonpalpable tumours b Square brackets and italics indicate QIs which were discontinued at the end of 2006 c number of radiation treatments to be recorded; exceptions require justification -- no specified requirement. Numbering and names, year of introduction, QI values for the 2003–2007 period (mean percentages across all participating institutions) and the required percentages for years 1 and 3 of DKG/DGS certification. | |||||||||
Brucker et al. BMC Cancer 2008 8:358 doi:10.1186/1471-2407-8-358 |
|||||||||